Skip to content Skip to footer
Lumasiran: Benefits, Reviews, Info, Side Effects!
Rx Details
Lumasiran
Oxlumo, ALN-18328
Lumasiran
Prescription
Drug
Drugs
Not FDA Classified
reduction of urinary oxalate levels, treatment of primary hyperoxaluria type 1, improvement in kidney function, potential delay in kidney stone formation, potential delay in kidney damage
Abdominal Pain, Back Pain, Diarrhea, Fatigue, Headache, Increased Liver Enzymes, Injection Site Reactions, Nasopharyngitis, Nausea, Pyrexia, Vomiting
Lumasiran is a medication used to treat primary hyperoxaluria type 1 (PH1). The dosage of lumasiran is typically based on the patient’s body weight. For pediatric and adult patients, the recommended dosing regimen is as follows: – For patients weighing less than 10 kg: 6 mg/kg once monthly for three doses, followed by 3 mg/kg once every three months. – For patients weighing 10 kg to less than 20 kg: 6 mg/kg once monthly for three doses, followed by 6 mg/kg once every three months. – For patients weighing 20 kg and above: 3 mg/kg once monthly for three doses, followed by 3 mg/kg once every three months. It’s important to note that these are general guidelines, and the exact dosage should be determined by a healthcare professional based on individual patient needs and response to treatment.
Primary hyperoxaluria type 1 (ph1)
Lumasiran has a favorable safety profile.
No Interactions Reported
$5,000 – $10,000
$750,000 for a year’s supply.

A Synopsis of

Lumasiran

Lumasiran is a groundbreaking medication that has shown great promise in the treatment of primary hyperoxaluria type 1 (PH1), a rare genetic disorder that can lead to the formation of kidney stones and potentially life-threatening kidney damage. This drug works by targeting the enzyme responsible for overproduction of oxalate, a key component in the formation of kidney stones.

Clinical trials have demonstrated the effectiveness of lumasiran in reducing urinary oxalate levels and preventing the recurrence of kidney stones in patients with PH1. This has led to improved kidney function and quality of life for many individuals suffering from this debilitating condition.

As with any medication, lumasiran may cause side effects in some patients. These can include injection site reactions, itching, and mild flu-like symptoms. It is important to discuss any concerns or potential side effects with your healthcare provider before starting treatment with lumasiran.

It is crucial to follow your healthcare provider’s instructions carefully when taking lumasiran to ensure optimal results. This may include regular monitoring of kidney function and urinary oxalate levels to track the effectiveness of the medication.

Overall, lumasiran represents a significant advancement in the treatment of PH1 and offers hope to patients who have previously had limited options for managing their condition. If you or a loved one has been diagnosed with PH1, talk to your healthcare provider about whether lumasiran may be a suitable treatment option for you.

RxDb Legal Disclaimer

The information provided on RxDB.net is for informational purposes only and is not intended to replace professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare professional, such as a doctor or pharmacist, for any questions or concerns regarding your health, medications, or medical conditions. Reliance on any information provided on this website is solely at your own risk. RxDB.net does not provide medical or pharmaceutical services and is not liable for any decisions made based on the information contained herein.

PAGE LAST UPDATED

Health Education Through Aggregation

Sign up for the Rx Database Newsletter!
Menu
Questions?

Website By Foxco © 2025. All rights reserved.

0
Would love your thoughts, please comment.x
()
x
en_USEN